Ryman Healthcare
Ryman Healthcare, a leading name in the aged care sector, is headquartered in New Zealand and operates extensively across the country and in Australia. Founded in 1984, the company has established itself as a pioneer in retirement living and aged care, with a commitment to providing high-quality services tailored to the needs of older adults. Ryman Healthcare offers a unique blend of independent living, assisted living, and rest home care, all designed to foster a sense of community and well-being among residents. The company is renowned for its innovative approach, including the development of purpose-built facilities that prioritise comfort and safety. With a strong market position, Ryman Healthcare has received numerous accolades for its services and facilities, reflecting its dedication to excellence in the industry. As it continues to expand, Ryman remains focused on enhancing the lives of its residents through compassionate care and vibrant living environments.
DitchCarbon Score
How does Ryman Healthcare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ryman Healthcare's score of 31 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ryman Healthcare's reported carbon emissions
In 2024, Ryman Healthcare, headquartered in New Zealand, reported total carbon emissions of approximately 14,000,000 kg CO2e. This figure includes 4,318,000 kg CO2e from Scope 1 emissions, 8,234,000 kg CO2e from Scope 2 emissions, and 1,418,000 kg CO2e from Scope 3 emissions related to business travel. Ryman Healthcare has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and 2 greenhouse gas emissions by 42% by FY2030, using FY2021 as the baseline year. Additionally, the company plans for 75.5% of its suppliers, based on spend, to have science-based targets by FY2028. These targets align with the Science Based Targets initiative (SBTi) and are designed to contribute to limiting global warming to 1.5°C. In 2021, Ryman's emissions were slightly lower, with Scope 1 emissions at 4,317,000 kg CO2e and Scope 2 emissions at 8,333,000 kg CO2e, alongside 469,000 kg CO2e from Scope 3 emissions. The company is actively working towards its reduction goals while maintaining transparency in its emissions reporting.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2024 | |
|---|---|---|
| Scope 1 | 4,317,000 | 0,000,000 |
| Scope 2 | 8,333,000 | 0,000,000 |
| Scope 3 | 469,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ryman Healthcare is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
